Antioxidants diminish developmental damage induced by high glucose cyclooxygenase inhibitors in rat embryos in vitro

Diabetes

Volumn 47, Issue 4, 1998, Pages 677-684

  Wentzel, Parri ^a   Eriksson, Ulf J ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ANTIOXIDANT; ARACHIDONIC ACID; GLUCOSE; INDOMETACIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CELL PROTECTION; EMBRYO; EMBRYOTOXICITY; FEMALE; GROWTH RETARDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TERATOGENESIS;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; ARACHIDONIC ACID; ASPIRIN; CULTURE TECHNIQUES; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; EMBRYO; EMBRYONIC AND FETAL DEVELOPMENT; GLUCOSE; INDOMETHACIN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 0031945983     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.4.677     Document Type: Article

References (48)

1. Pedersen J: The Pregnant Diabetic and Her Newborn. 2nd ed. Copenhagen, Munksgaard, 1977
2. Mills JL, Baker L, Goldman AS: Malformations in infants of diabetic mothers occur before the seventh gestational week: implications for treatment. Diabetes 28:292-293, 1979
3. Eriksson UJ, Borg LAH, Forsberg H, Simán CM, Suzuki N, Yang X: Can fetal loss be prevented? The biochemical basis of diabetic embryopathy. Diabetes Rev 4:49-69, 1996
4. Geissler FT, Kuzan FB, Faustman EM, Henderson WR Jr: Lipid mediator production by post-implantation rat embryos in vitro. Prostaglandins 38: 145-163, 1989
5. Goldman AS, Baker L, Piddington R, Marx B, Herold R, Egler J: Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci USA 82:8227-8231, 1985
6. Pinter E, Reece EA, Leranth CS, Garcia-Segura M, Hobbins JC, Mahoney MJ, Naftolin F: Arachidonic acid prevents hyperglycemia-associated yolk sac damage and embryopathy. Am J Obstet Gynecol 155:691-702, 1986
7. Baker L, Piddington R, Goldman A, Egler J, Moehring J: Myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos. Diabetologia 33:593-596, 1990
8. 2 prevents anomalies induced by hyperglycemia or diabetic serum in mouse embryos. Diabetes 41:1644-1650, 1992
9. 2 levels in mouse embryos during neurulation. Diabetologia 39:915-920, 1996
10. Eriksson UJ, Borg LAH: Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34:325-331, 1991
11. Eriksson UJ, Borg LAH: Diabetes and embryonic malformations: role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42:411-419, 1993
12. Hagay ZJ, Weiss V, Zusman I, Peted-Kamar M, Reece EA, Eriksson UJ, Groner Y: Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 173:1036-1041, 1995
13. Eriksson UJ, Simán CM: Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring. Diabetes 45:1497-1502, 1996
14. Yang X, Borg LAH, Eriksson UJ: Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 272:E173-E180, 1997
15. Trocino RA, Akazawa S, Ishibasni M, Matsumoto K, Matsuo H, Yamamoto H, Goto S, Urata Y, Hondo T, Nagataki S: Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44:992-998, 1995
16. Viana M, Herrera E, Bonet B: Teratogenic effects of diabetes mellitus in the rat: prevention with vitamin E. Diabetologia 39:1047-1054, 1996
17. Sivan E, Reece EA, Wu YK, Homko CJ, Polansky M, Borenstein M: Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol 175:793-799, 1996
18. Simán CM, Eriksson UJ: Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 46:1054-1061, 1997
19. Simán CM, Eriksson UJ: Malformations in the offspring of diabetic rats are prevented by supplementation of the maternal diet with vitamin C. Diabetologia 40:1416-1424, 1997
20. Loeken MR: Vitamin E may exacerbate the embryopathic effects of diabetic pregnancy (Abstract). Diabetes 46 (Suppl. 1):259A, 1997
21. Sakamaki H, Akazawa S, Ishibasni M, Izumino K, Abiru N, Kondo H, Takino H, Yamasaki H, Yamaguchi Y, Kondo T, Nagataki S: Diabetes-induced embryopathy and glutathione-dependent antioxidant system (Abstract), Diabetes 46 (Suppl. 1):88A, 1997
22. Potashnik Y, Ayalon N, Khamaisi M, Wiznitzer A, Bashan N: Lipoic acid treatment decreases neural tube defects in fetuses of diabetic rats (Abstract), Diabetologia 40 (Suppl. 1):A585, 1997
23. Wentzel P, Thunberg L, Eriksson UJ: Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and, N-acetylcysteine in rat embryo culture. Diabetologia 40:7-14, 1997
24. Yang X, Borg LAH, Eriksson UJ: Altered mitochondrial morphology of rat embryos in diabetic pregnancy. Anat Rec 241:255-267, 1995
25. Eriksson UJ: Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats. Teratology 37:366-374, 1988
26. New DAT: Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol Rev 53:81-122, 1978
27. Wentzel P, Eriksson UJ: Insulin treatment fails to abolish the teratogenic potential of serum from diabetic rats. Eur J Endocrinol 134:459-466, 1996
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Polin phenol reagent. J Biol Chem 193:265-275, 1951
29. Kissane JM, Robins E: The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem 233:184-188, 1958
30. Hinegardner RT: An improved fluorometric assay for DNA. Anal Biochem 39:197-201, 1971
31. Winer BJ: Statistical Principles in Experimental Design. New York, McGraw-Hill, 1971
32. Ostle B: Statistics in Research. 2nd ed. Ames, Iowa, Iowa State University, 1963
33. Cockroft DL, Coppola PT: Teratogenic effects of excess glucose on head-fold rat embryos in culture. Teratology 16:141-146, 1977
34. Sadler TW: Effects of maternal diabetes on early embryogenesis. I. The teratogenic potential of diabetic serum. Teratology 21:339-347, 1980
35. Styrud J, Thunberg L, Nybacka O, Eriksson UJ: Correlations between maternal metabolism and deranged development in the offspring of normal and diabetic rats. Pediatr Res 37:343-353, 1995
36. Mills JL, Knopp RH, Simpson JL, Jovanovic-Peterson L, Metzger BE, Holmes LB, Aarons JH, Brown Z, Reed GF, Bieber FR, Van Allen M, Holzman I, Ober C, Peterson CM, Withiam MJ, Duckles A, Mueller Heubach E, Polk BF, National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study Group: Lack of relation of increased malformation rates in infants of diabetic mothers to glycemie control during organogenesis. N Engl J Med 318:671-676, 1988
37. Buchanan TA, Denno KM, Sipos GF, Sadler TW; Diabetic teratogenesis: in vitro evidence for a multifactorial etiology with little contribution from glucose per se. Diabetes 43:656-660, 1994
38. Suzuki N, Svensson K, Eriksson UJ: High glucose concentration inhibits migration of rat cranial neural crest cells in vitro. Diabetotogia 39:401-411, 1996
39. Stuart MJ, Sunderji SG, Allen JB; Decreased prostacyclin production in the infant of the diabetic mother. J Lab Clin Med 98:412-416, 1981
40. Kuhn DC, Botti JJ, Cherouny PH, Demers LM: Eicosanoid production and transfer in the placenta of the diabetic pregnancy. Prostaglandins 40:205-214, 1990
41. Fowden AL, Ralph MM, Silver M: Nutritional regulation of uteroplacental prostaglandin production and metabolism in pregnant ewes and mares during late gestation. Exp Clin Endocrinol 102:212-221, 1994
42. 2in diabetic pregnancy: further clues to the etiology of diabetic embryopathy. Prostaglandins 50:121-126, 1995
43. Engstrom E, Haglund A, Eriksson UJ: Effects of maternal diabetes or in vitro hyperglycemia on uptake of palmitic and arachidonic acid by rat embryos. Pediatr Res 30:150-153, 1991
44. Pinter E, Reece EA, Ogburn PL, Turner S, Hobbins JC, Mahoney MJ, Naftolin F: Fatty acid content of yolk sac and embryo in hyperglycemia-induced embryopathy and effect of arachidonic acid supplementation. Am J Obstet Gynecol 159:1484-1490, 1988
45. Eriksson UJ, Naeser P, Brolin SE: Increased accumulation of sorbitol in embryos of manifest diabetic rats. Diabetes 35:1356-1363, 1986
46. Hod M, Star S, Passonneau JV, Unterman TG, Freinkel N: Effect of hyperglycemia on sorbitol and myo-inositol content of cultured rat conceptus; failure of aldose reductase inhibitors to modify myo-inositol depletion and dysmorphogenesis. Biochem Biophys Res Comm 140:974-980, 1986
47. Tanaka Y, Ward SL, Smith WL Immunochemical and kinetic evidence for two different prostaglandin H-prostaglandin E isomerases in sheep vesicular gland microsomes. J Biol Chem 262:1374-1381, 1987
48. Asboth G, Gimes G, Herteleny F, Toth M: The relation between thromboxane and prostaglandin synthesis in human decidua tissue: a comparison of eicosanoid synthesis in minced tissue with that in a cell-free preparation. Biochim Biophys Acta 1002:101-108, 1989